Derek K Chu, Alexandro W L Chu, Daniel G Rayner, Gordon H Guyatt, Juan José Yepes-Nuñez, Luis Gomez-Escobar, Lucia C Pérez-Herrera, Juan Pablo Díaz Martinez, Romina Brignardello-Petersen, Behnam Sadeghirad, Melanie M Wong, Renata Ceccacci, Irene X Zhao, John Basmaji, Margaret MacDonald, Xiajing Chu, Nazmul Islam, Ya Gao, Ariel Izcovich, Rachel N Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Korey Capozza, Lina Chen, Kathy Ellison, Winfred T Frazier, Matthew Greenhawt, Joey Huynh, Jennifer LeBovidge, Peter A Lio, Stephen A Martin, Monica O'Brien, Peck Y Ong, Jonathan I Silverberg, Jonathan M Spergel, Wendy Smith Begolka, Julie Wang, Kathryn E Wheeler, Donna D Gardner, Lynda Schneider
BACKGROUND: Atopic dermatitis (AD) is a common skin condition with multiple topical treatment options, but uncertain comparative effects. OBJECTIVE: We sought to systematically synthesize the benefits and harms of AD prescription topical treatments. METHODS: For the 2023 American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma, and Immunology Joint Task Force on Practice Parameters AD guidelines, we searched MEDLINE, EMBASE, CENTRAL, CINAHL, LILACS, ICTRP, and GREAT databases to September 5, 2022, for randomized trials addressing AD topical treatments...
December 2023: Journal of Allergy and Clinical Immunology